Results 31 to 40 of about 47,907 (235)

ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study

open access: yesHaematologica, 2013
Anaplastic large cell lymphomas are peripheral T-cell lymphomas that are characterized by a proliferation of large anaplastic blasts expressing CD30.
Ilske Oschlies   +17 more
doaj   +1 more source

ALK+ Anaplastic large cell lymphoma with extensive cardiac involvement: A rare case report and review of the literature

open access: yesAutopsy and Case Reports, 2021
Cardiac lymphoma is a rare entity. In this setting, the secondary involvement of the heart is far more frequent than the primary cardiac lymphoma. Herein, we present an autopsy case of a disseminated anaplastic lymphoma kinase (ALK)- positive anaplastic ...
Kaniyappan Nambiyar   +4 more
doaj  

Primary cutaneous anaplastic large cell lymphoma initially clinically considered to be pyoderma gangrenosum

open access: yesMedicine Science, 2017
Primary CD30+ anaplastic large cell lymphoma, which is generally seen in adults, is the second most common cutaneous T-cell lymphoma after mycosis fungoides. The lesions are characterized by red-brown plaque or nodules often with ulceration.
Serpil Sener   +2 more
doaj   +1 more source

Cardiac Tamponade Associated with the Presentation of Anaplastic Large Cell Lymphoma in a 2-Year-Old Child

open access: yesCase Reports in Pediatrics, 2015
The anaplastic large cell lymphoma is a rare entity in pediatric patients. We present an unusual case of pericardial involvement, quite uncommon as extranodal presentation of this type of disorder, that provoked a life-risk situation requiring an urgent ...
Gema Mira-Perceval Juan   +7 more
doaj   +1 more source

Young survivor of a rare primary anaplastic large cell lymphoma of the trachea

open access: yesProceedings of Singapore Healthcare, 2021
Primary anaplastic large cell lymphoma of the trachea is a very rare tumor. Diagnosis is often missed for a long time because the presentation often resembles that of obstructive airway disease.
Jehanzeb Shahid   +4 more
doaj   +1 more source

Treating cutaneous T-cell lymphoma with highly irregular surfaces with photon irradiation using rice as tissue compensator. [PDF]

open access: yes, 2015
PurposeCutaneous T-cell lymphoma (CTCL) is known to have an excellent response to radiotherapy, an important treatment modality for this disease.
Chakravarti, Arnab   +9 more
core   +2 more sources

Anaplastic large cell lymphoma

open access: yes, 2019
Anaplastic Large Cell Lymphoma (ALCL) describes a distinct group of T cell lymphomas characterized by cell surface expression of CD30. At least 3 entities of ALCL exist, with similar cellular morphology but varying clinical courses and pathology: systemic ALCL, Anaplastic Lymphoma Kinase (ALK)-positive, systemic ALCL ALK- and primary cutaneous ALCL.
Dr.Eapen Thomas, Dr.Latha K Abraham
  +7 more sources

Aggressive Disease Course of Multiple Myeloma with Concomitant ALK-Negative Anaplastic Large Cell Lymphoma: A Case Report with an Unusual Presentation

open access: yesCase Reports in Hematology, 2020
ALK-negative anaplastic large cell lymphoma is a rare T-cell neoplasm with an aggressive course requiring prompt diagnostic work-up and treatment. Few cases of concomitant multiple myeloma and T-cell neoplasm are described in the literature, mainly ...
Michela Staderini   +9 more
doaj   +1 more source

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead [PDF]

open access: yes, 2015
Non-Hodgkin lymphoma is the fourth most common malignancy in children, has an even higher incidence in adolescents, and is primarily represented by only a few histologic subtypes. Dramatic progress has been achieved, with survival rates exceeding 80%, in
Auperin, Anne   +23 more
core   +1 more source

Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung Cancer. [PDF]

open access: yes, 2015
BackgroundPemetrexed is approved in the treatment of advanced stage nonsquamous non-small-cell lung cancer (NSCLC). The length of response is variable, and we thus sought to identify which clinicopathologic characteristics are associated with long-term ...
Liang, Ying   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy